Instapath
instapathbio.comTransform tissue samples into digital images in minutes, zero cutting, zero fixing.
Hardware & IoTpathologymedical-devicemicroscopytissue-imagingdigital-pathologylife-sciencespoint-of-care
About
Instapath develops fluorescence microscopy imaging platforms that digitize fresh pathology tissue samples in minutes at the point of procedure, with no cutting, fixing, or tissue loss. Their hardware lineup includes Nova (a Class I medical device for immediate tissue composition analysis), Luci (for large specimen imaging without destructive processing), and LuciNow (a remote on-demand slide scanning service). The technology preserves tissue integrity for downstream analytical testing while enabling rapid, high-quality previews without repeat procedures.
Problem
Current immediate evaluation techniques in pathology destroy tissue samples and prevent physicians from previewing entire specimens, often leading to repeat procedures.
For
Physicians, pathologists, and medical researchers performing tissue biopsies and specimen analysis
How it works
Patented fluorescence microscopy imaging platforms digitize fresh, fixed, or frozen tissue samples within minutes at the point of procedure without cutting or fixing the tissue.
Business model
unknown
Status
launched
Company
Instapath Inc.